Literature DB >> 33318711

Correlation between hospitalized patients' demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil.

Márcio C F Macedo1, Isabelle M Pinheiro2,3, Caio J L Carvalho1,4, Hilda C J R Fraga3,5, Isaac P C Araujo6, Simone S Montes3, Otávio A C Araujo1, Lucas A Alves6, Hugo Saba3,7, Márcio L V Araújo8,3,9, Ivonete T L Queiroz10, Romilson L Sampaio3,11, Márcia S P L Souza9, Ana Claudia F N da Silva9, Antonio C S Souza3,11.   

Abstract

In this paper, we provide a retrospective cohort study with patients that have been hospitalized for general or intensive care unit admission due to COVID-19, between March 3 and July 29, 2020, in the state of Bahia, Brazil. We aim to correlate those patients' demographics, symptoms and comorbidities, with the risk of mortality from COVID-19, length of hospital stay, and time from diagnosis to definitive outcome. On the basis of a dataset provided by the Health Secretary of the State of Bahia, we selected 3,896 hospitalized patients from a total of 154,868 COVID-19 patients that included non-hospitalized patients and patients with invalid registration in the dataset. Then, we statistically analyzed whether there was a significant correlation between the patient record data and the COVID-19 pandemic, and our main findings reinforced by the use of a multivariable logistic regression were that older age (Odds Ratio [OR] = 1.03, 95% Confidence Interval [CI] = 1.03-1.04, p-value (p) <0.001), an initial symptom of shortness of breath (OR = 1.88, 95% CI = 1.60-2.20, p < 0.001), and the presence of comorbidities, mainly chronic kidney disease (OR = 2.41, 95% CI = 1.67-3.48, p < 0.001) are related to an increased risk of mortality from COVID-19. On the other hand, sore throat (OR = 0.74, 95% CI = 0.58-0.95, p = 0.02) and length of hospital stay (OR = 0.96, 95% CI = 0.58-0.95, p < 0.001) are more related to a reduced risk of mortality from COVID-19. Moreover, a multivariable linear regression conducted with statistically significant variables (p < 0.05) showed that age (OR = 0.97, 95% CI = 0.95-0.98, p < 0.001) and time from diagnosis to definitive outcome (OR = 1.67, 95% CI = 1.64-1.71, p < 0.001) are associated with the length of hospital stay.

Entities:  

Year:  2020        PMID: 33318711     DOI: 10.1371/journal.pone.0243966

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  7 in total

1.  Epidemiology of COVID-19 in Tehran, Iran: A Cohort Study of Clinical Profile, Risk Factors, and Outcomes.

Authors:  Hamidreza Hatamabadi; Tahereh Sabaghian; Amir Sadeghi; Kamran Heidari; Seyed Amir Ahmad Safavi-Naini; Mehdi Azizmohammad Looha; Nazanin Taraghikhah; Shayesteh Khalili; Keivan Karrabi; Afsaneh Saffarian; Saba Shahsavan; Hossein Majlesi; Amirreza Allahgholipour Komleh; Saba Hatari; Nadia Zameni; Saba Ilkhani; Shideh Moftakhari Hajimirzaei; Aydin Ghaffari; Mohammad Mahdi Fallah; Reyhaneh Kalantar; Nariman Naderi; Parnian Bahmaei; Naghmeh Asadimanesh; Romina Esbati; Omid Yazdani; Fatemeh Shojaeian; Zahra Azizan; Nastaran Ebrahimi; Fateme Jafarzade; Amirali Soheili; Fatemeh Gholampoor; Negarsadat Namazi; Ali Solhpour; Tannaz Jamialahamdi; Mohamad Amin Pourhoseingholi; Amirhossein Sahebkar
Journal:  Biomed Res Int       Date:  2022-05-10       Impact factor: 3.246

2.  Synchronized spread of COVID-19 in the cities of Bahia, Brazil.

Authors:  Hugo Saba; A S Nascimento Filho; José G V Miranda; Raphael S Rosário; Thiago B Murari; Eduardo M F Jorge; Elaine C B Cambui; Márcia S P L Souza; Ana C F N Silva; Márcio L V Araújo
Journal:  Epidemics       Date:  2022-06-01       Impact factor: 5.324

3.  Correction: Correlation between hospitalized patients' demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil.

Authors:  Márcio C F Macedo; Isabelle M Pinheiro; Caio J L Carvalho; Hilda C J R Fraga; Isaac P C Araujo; Simone S Montes; Otávio A C Araujo; Lucas A Alves; Hugo Saba; Márcio L V Araújo; Ivonete T L Queiroz; Romilson L Sampaio; Márcia S P L Souza; Ana Claudia F N da Silva; Antonio C S Souza
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

Review 4.  COVID-19 and chronic kidney disease: an updated overview of reviews.

Authors:  Sara S Jdiaa; Razan Mansour; Abdallah El Alayli; Archana Gautam; Preston Thomas; Reem A Mustafa
Journal:  J Nephrol       Date:  2022-01-11       Impact factor: 3.902

5.  Risk assessment and rationalization of health resource allocation: Lessons from the Brazilian COVID-19 cohort in 2020.

Authors:  Vitória Berg Cattani; Thaís Araujo Dos Santos; Julio Castro-Alves; Marcelo Ribeiro-Alves
Journal:  Prev Med Rep       Date:  2022-02-02

Review 6.  COVID-19 in Latin America and the caribbean region: Symptoms and morbidities in the epidemiology of infection.

Authors:  Julio Y Anaya-Covarrubias; Antonio Pizuorno; Santiago Mirazo; Jesus Torres-Flores; Gisela Du Pont; Edmundo Lamoyi; Nora A Fierro
Journal:  Curr Opin Pharmacol       Date:  2022-02-11       Impact factor: 4.768

7.  A Critical Analysis of the COVID-19 Hospitalization Network in Countries with Limited Resources.

Authors:  Marcio L V Araujo; José G V Miranda; Rodrigo N Vasconcelos; Elaine C B Cambui; Raphael S Rosário; Márcio C F Macedo; Antonio C Bandeira; Márcia S P L Souza; Ana C F N Silva; Aloisio S Nascimento Filho; Thiago B Murari; Eduardo M F Jorge; Hugo Saba
Journal:  Int J Environ Res Public Health       Date:  2022-03-24       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.